Celestica director Wilson sells $2.46 million in shares

Celestica (CLS) significantly surpassed Q2 2025 expectations with adjusted EPS of $1.39 and revenue of $2.89 billion, prompting an upward revision of its full-year guidance and leading Stifel and RBC Capital to raise price targets to $230 and $225, respectively, citing strong AI and hyperscaler demand. Amidst this momentum and a 413% stock gain over the past year, Director Michael Max Wilson sold 25,000 shares for $2.46 million at an average of $98.73, while the company also appointed Chris Colpitts to its Board of Directors.

Analysis

Celestica (CLS) is exhibiting substantial fundamental momentum, underscored by a significant Q2 2025 earnings beat and an upward revision of its full-year guidance. The company posted an adjusted EPS of $1.39, outperforming the $1.23 forecast, on revenue of $2.89 billion, which exceeded the anticipated $2.67 billion. This robust performance prompted management to raise full-year projections to $11.55 billion in revenue and $5.50 in adjusted EPS. The market and analyst community have responded positively, reflected in the stock's 413% gain over the past year and recent price target increases from Stifel and RBC Capital to $230 and $225, respectively, with both firms citing strong demand driven by AI and hyperscalers. This bullish outlook is contrasted by a notable insider transaction, where Director Michael Max Wilson sold 25,000 shares for $2.46 million as the stock neared its 52-week high. While the sale is significant in dollar terms, it follows a period of extreme share price appreciation. The company's governance was also strengthened with the appointment of Chris Colpitts, an experienced technology executive, to its Board of Directors.

Key Decisions for Investors

• Given the strong earnings beat, raised guidance, and bullish analyst price targets hinging on AI-driven demand, investors may consider the company's fundamental strength to be intact, justifying a positive outlook.
• The significant insider sale by a director near the 52-week high warrants attention; investors should monitor for further insider selling, which could signal that management perceives the valuation as full after the stock's 413% run-up.
• For those holding positions, the combination of strong performance and a large stock price increase may present an opportunity to review position sizing and potentially trim profits to manage risk.